Evidence supporting the use of: Immunoglobulin
For the health condition: Contagious Diseases
Synopsis
Source of validity: Scientific
Rating (out of 5): 5
Immunoglobulin, also known as intravenous immunoglobulin (IVIG), is scientifically validated for use in the prevention and treatment of certain contagious diseases. Immunoglobulin preparations are derived from the pooled plasma of thousands of healthy donors and contain a broad spectrum of antibodies against various pathogens. Their use is well established in both prophylactic and therapeutic contexts, especially for individuals with primary or secondary immunodeficiencies who cannot produce adequate antibodies themselves. Furthermore, specific immunoglobulin preparations (such as hepatitis B immune globulin, rabies immune globulin, and tetanus immune globulin) are routinely administered post-exposure to prevent the onset of diseases in non-immune individuals.
The mechanism of action involves passive immunization, where pre-formed antibodies neutralize pathogens or their toxins, providing immediate but temporary protection. This approach is particularly important for diseases where vaccination is not possible, immunity is insufficient, or immediate protection is required after exposure. The efficacy of immunoglobulin in such scenarios has been demonstrated in multiple clinical trials and is supported by guidelines from organizations like the CDC, WHO, and national immunization bodies. In summary, immunoglobulin is a scientifically validated and routinely used intervention for the prevention and treatment of a range of contagious diseases, especially in high-risk or immunocompromised populations.
Other health conditions supported by immunoglobulin
Autoimmune DisordersBlood Poisoning
Cancer Treatment (reducing side effects)
Chemotherapy (reducing side effects)
Contagious Diseases
Hepatitis
Infection
Infection (bacterial)
Infection (viral)
Inflammation
Influenza
Lupus
Lymphoma
Meningitis
Myasthenia Gravis
Pneumonia
Staph Infections
Wounds and Sores